Abstract
ObjectiveTo investigate the efficacy and safety of the interleukin-6 receptor antibody tocilizumab in patients with Takayasu arteritis (TAK).MethodsPatients with TAK who had relapsed within the previous 12 weeks were induced...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have